AmyBrooks-KayalMDFAAN, FAES, FANA

PubMed

• 146 citations
  Targeted Loss of Arx Results in a Developmental Epilepsy Mouse Model and Recapitulates the Human Phenotype in Heterozygous Females
  Eric D. Marsh, Carl T. Fulp, Ernest D. Gomez, Ilya M. Nasrallah, Jeremy Minarcik
  Brain. 2009-06-01
• 31 citations
  FACS-array gene expression analysis during early development of mouse telencephalic interneurons.
  Eric D. Marsh, Jennifer Minarcik, Kenneth Campbell, Amy R. Brooks-Kayal, Jeffrey A. Golden
  Developmental Neurobiology. 2008-03-01
• 93 citations
  Two Tyrosine Residues on the α Subunit Are Crucial for Benzodiazepine Binding and Allosteric Modulation of γ-Aminobutyric Acid A Receptors
  Jahanshah Amin, Amy R. Brooks-Kayal, David S. Weiss
  Molecular Pharmacology. 1997-05-01

Lectures

• Your Grant was Rejected. Now What? 
  Los Angeles, CA - 1/1/2018
• Women in Neuroscience 
  Los Angeles, CA - 1/1/2018
• Getting from Mechanisms to Therapies: New Treatments on the Horizon for Epilepsy 
  Orlando, FL, 2018; Trinidad, 2018 - 1/1/2018
• Getting from mechanism to medicine: Insights from an academic�s journey into translational epilepsy research 
  New Haven, CT, 2016; New York, NY, 2017 - 1/1/2017
• Getting from mechanism to medicine: Opportunities and Challenges in the development of new therapies for epilepsy 
  Layfayette, IN - 1/1/2017
• Epilepsy at the Cutting Edge: Using Novel Models for Therapeutic Advances 
  Boston, MA - 1/1/2017
• From Mechanism to Medicine: Modifying signaling pathways to prevent post-traumatic epilepsy 
  Denver, CO - 1/1/2017
• Neurobehavioral Co-morbidities in Pediatric Epilepsy 
  Linkoping, Sweden - 1/1/2017
• Advances in Translational Epilepsy 
  Linkoping, Sweden - 1/1/2017
• Epilepsy at the Cutting Edge: using novel models and innovative approaches to make therapeutic advances 
  Washington, DC - 1/1/2017
• BDNF & JAK/STAT Regulation after Brain Injuries Potential New Targets for Disease Modification for Acquired Epilepsy? 
  University of Aix-Marseille, Marseille, France - 1/1/2016
• JAK/STAT Regulation after Brain Injuries Potential New Targets for Disease Modification for Acquired Epilepsy? 
  Waco, TX - 1/1/2016
• Cannabinoids for Treatment of Pediatric Epilepsy: The Hype And The Evidence 
  NIH Campus, Bethesda, MD - 1/1/2016
• Getting to Cure: Opportunities and Challenges on the Road to Disease Modifying Therapies for Epilepsy 
  Department of Biomedical Sciences, College of Veterinary Medicine, Iowa State University, Ames, IA - 1/1/2016
• JAK/STAT Regulation after Brain Injury: Potential New Targets for Disease Modification 
  Breckenridge, CO - 1/1/2016
• Cannabinoids 
  Washington DC - 1/1/2015
• Getting to Cure: Opportunities and Challenges on the Road to Disease Modifying and Preventative Therapies for Epilepsy 
  Boston University, Department of Pharmacology - 1/1/2015
• Comorbid Cognitive and Neuropsychiatric Disorders of Epilepsy and CNS Disorders with Seizures 
  Park City Utah - 1/1/2015
• Regulating aberrant plasticity after brain injury; following novel pathways to find new treatments 
  Taormina, Sicily, Italy - 1/1/2015
• Animal Models of Epilepsy Co-Morbidities: What do they tell us about mechanisms 
  Istanbul, Turkey - 1/1/2015
• JAK/STAT pathway activation as a molecular biomarker of epileptogenesis and cognitive co-morbidities after brain injury 
  Heybeliada Island, Istanbul, Turkey - 1/1/2015
• Strategic Planning 
  Istanbul, Turkey - 1/1/2015
• The challenge and promise of developing disease modifying therapies for epilepsy 
  Washington, DC - 1/1/2015
• BDNF and JAK/STAT regulation after brain injury: potential new targets for disease modification in epilepsy 
  Estes Park, CO - 1/1/2015
• Why make the journey: The need for disease modifying and preventative therapies for epilepsy 
  Philadelphia, PA - 1/1/2015
• Join now to see all